Christopherson K, Hromas R
Indiana University Cancer Center and the Walther Oncology Institute, Indianapolis, Indiana 46202, USA.
Stem Cells. 2001;19(5):388-96. doi: 10.1634/stemcells.19-5-388.
Chemokines are small basic proteins that are the major mediators of all leukocyte migration. There are at least 46 distinct chemokines, and 19 chemokine receptors, making it easily the largest cytokine family. Chemokines can be both beneficial and harmful, by either stimulating an appropriate immune response to microbial invasion, or by mediating pathologic tissue destruction in many types of human disease. Chemokines have been implicated in the tissue destruction seen in autoimmune diseases, atherosclerosis, allograft rejection, and neoplasia. Chemokines also play essential roles in normal lymphocyte trafficking to primary and secondary lymphoid organs for antigen presentation and lymphocyte maturation. Chemokines also regulate hematopoietic stem and progenitor cell homing and proliferation. Therefore, it is likely that chemokines will become important targets for pharmacologic intervention in a wide variety of human diseases in the future.
趋化因子是一类小的碱性蛋白质,是所有白细胞迁移的主要介质。至少有46种不同的趋化因子和19种趋化因子受体,这使其轻松成为最大的细胞因子家族。趋化因子既有益也有害,既能刺激对微生物入侵的适当免疫反应,也能在多种人类疾病中介导病理性组织破坏。趋化因子与自身免疫性疾病、动脉粥样硬化、同种异体移植排斥反应和肿瘤形成中的组织破坏有关。趋化因子在正常淋巴细胞迁移至初级和次级淋巴器官以进行抗原呈递和淋巴细胞成熟过程中也发挥着重要作用。趋化因子还调节造血干细胞和祖细胞的归巢和增殖。因此,趋化因子未来很可能会成为多种人类疾病药物干预的重要靶点。